Programmable release of multiple protein drugs from aptamer-functionalized hydrogels via nucleic acid hybridization.

Polymeric delivery systems have been extensively studied to achieve localized and controlled release of protein drugs. However, it is still challenging to control the release of multiple protein drugs in distinct stages according to the progress of disease or treatment. This study successfully demonstrates that multiple protein drugs can be released from aptamer-functionalized hydrogels with adjustable release rates at predetermined time points using complementary sequences (CSs) as biomolecular triggers. Because both aptamer-protein interactions and aptamer-CS hybridization are sequence-specific, aptamer-functionalized hydrogels constitute a promising polymeric delivery system for the programmable release of multiple protein drugs to treat complex human diseases.

[1]  D. Pettit,et al.  Biodegradable polymers for protein and peptide drug delivery. , 1995, Bioconjugate chemistry.

[2]  D. Mooney,et al.  Growth factor delivery-based tissue engineering: general approaches and a review of recent developments , 2011, Journal of The Royal Society Interface.

[3]  J. Szostak,et al.  In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.

[4]  K. Anseth,et al.  Photopolymerization of multilaminated poly(HEMA) hydrogels for controlled release. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[5]  R Langer,et al.  Responsive polymeric delivery systems. , 2001, Advanced drug delivery reviews.

[6]  J. Pearlman,et al.  Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study. , 2000, Journal of the American College of Cardiology.

[7]  Yi Lu,et al.  Abasic site-containing DNAzyme and aptamer for label-free fluorescent detection of Pb(2+) and adenosine with high sensitivity, selectivity, and tunable dynamic range. , 2009, Journal of the American Chemical Society.

[8]  R. Kennedy,et al.  Retention and separation of adenosine and analogues by affinity chromatography with an aptamer stationary phase. , 2001, Analytical chemistry.

[9]  Ralph Müller,et al.  Repair of bone defects using synthetic mimetics of collagenous extracellular matrices , 2003, Nature Biotechnology.

[10]  Yong Wang,et al.  Affinity hydrogels for controlled protein release using nucleic acid aptamers and complementary oligonucleotides. , 2011, Biomaterials.

[11]  V. Torchilin,et al.  Biodegradable long-circulating polymeric nanospheres. , 1994, Science.

[12]  A. Feldman,et al.  Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  R. Langer,et al.  Designing materials for biology and medicine , 2004, Nature.

[14]  B. Sullenger,et al.  RNA aptamers as reversible antagonists of coagulation factor IXa , 2002, Nature.

[15]  T. Fan,et al.  The Formulation of Aptamer-coated Paclitaxel–polylactide Nanoconjugates and Their Targeting to Cancer Cells , 2022 .

[16]  R. Ross,et al.  Purification of human platelet-derived growth factor. , 1985, Methods in Enzymology.

[17]  Michael Famulok,et al.  Aptamer modules as sensors and detectors. , 2011, Accounts of chemical research.

[18]  Yingfu Li,et al.  Structure-switching signaling aptamers. , 2003, Journal of the American Chemical Society.

[19]  D. Mooney,et al.  Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.

[20]  B. Sullenger,et al.  Aptamers: an emerging class of therapeutics. , 2005, Annual review of medicine.

[21]  S. Jayasena.  Aptamers: an emerging class of molecules that rival antibodies in diagnostics. , 1999, Clinical chemistry.

[22]  Stimuli-induced Pulsatile or Triggered Release Delivery Systems for Bioactive Compounds , 2007 .

[23]  George W. Jackson,et al.  Biophysical characterization of DNA aptamer interactions with vascular endothelial growth factor , 2009, Biopolymers.

[24]  Xiaoling Zhang,et al.  An aptamer cross-linked hydrogel as a colorimetric platform for visual detection. , 2010, Angewandte Chemie.

[25]  W. Carter,et al.  Side effects resulting from the use of growth hormone and insulin-like growth factor-I as combined therapy to frail elderly patients. , 1998, The journals of gerontology. Series A, Biological sciences and medical sciences.

[26]  M. Shoichet,et al.  Tunable Growth Factor Delivery from Injectable Hydrogels for Tissue Engineering , 2011, Journal of the American Chemical Society.

[27]  Omid C. Farokhzad,et al.  Nanoparticle-Aptamer Bioconjugates , 2004, Cancer Research.

[28]  Jeroen Lammertyn,et al.  Real-time monitoring of DNA hybridization and melting processes using a fiber optic sensor , 2012, Nanotechnology.

[29]  L. Gold,et al.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.

[30]  Antonios G Mikos,et al.  Gelatin as a delivery vehicle for the controlled release of bioactive molecules. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[31]  J. Hubbell,et al.  Development of fibrin derivatives for controlled release of heparin-binding growth factors. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[32]  N. Peppas,et al.  Hydrogels in Pharmaceutical Formulations , 1999 .

[33]  Jason A Burdick,et al.  Delivery of osteoinductive growth factors from degradable PEG hydrogels influences osteoblast differentiation and mineralization. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[34]  Nebojsa Janjic,et al.  Inhibitory DNA ligands to platelet-derived growth factor B-chain. , 1996, Biochemistry.

[35]  Y. Mi,et al.  Capture and release of protein by a reversible DNA-induced sol-gel transition system. , 2008, Angewandte Chemie.

[36]  Yong Wang,et al.  Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras , 2006, Nature Biotechnology.

[37]  Friedrich C Simmel,et al.  A DNA-based machine that can cyclically bind and release thrombin. , 2004, Angewandte Chemie.

[38]  M. Fishman,et al.  A Phase 1 Dose Escalation, Pharmacokinetic, and Pharmacodynamic Evaluation of eIF-4E Antisense Oligonucleotide LY2275796 in Patients with Advanced Cancer , 2011, Clinical Cancer Research.

[39]  Kristi S. Anseth,et al.  Fundamental studies of a novel, biodegradable PEG-b-PLA hydrogel , 2000 .